3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prospective observational study of mechanical cardiopulmonary resuscitation, extracorporeal membrane oxygenation and early reperfusion for refractory cardiac arrest in Sydney: the 2CHEER study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Patients with prolonged cardiac arrest that is not responsive to conventional cardiopulmonary resuscitation have poor outcomes. The use of extracorporeal membrane oxygenation (ECMO) in refractory cardiac arrest has shown promising results in carefully selected cases. We sought to validate the results from an earlier extracorporeal cardiopulmonary resuscitation (ECPR) study (the CHEER trial

          Methods: Prospective, consecutive patients with refractory in-hospital (IHCA) or out-of-hospital cardiac arrest (OHCA) who met predefined inclusion criteria received protocolised care, including mechanical cardiopulmonary resuscitation, initiation of ECMO, and early coronary angiography (if an acute coronary syndrome was suspected).

          Results: Twenty-five patients were enrolled in the study (11 OHCA, 14 IHCA); the median age was 57 years (interquartile range [IQR], 39–65 years), and 17 patients (68%) were male. ECMO was established in all patients, with a median time from arrest to ECMO support of 57 minutes (IQR, 38–73 min). Percutaneous coronary intervention was performed on 18 patients (72%). The median duration of ECMO support was 52 hours (IQR, 24–108 h). Survival to hospital discharge with favourable neurological recovery occurred in 11/25 patients (44%, of which 72% had IHCA and 27% had OHCA). When adjusting for lactate, arrest to ECMO flow time was predictive of survival (odds ratio, 0.904; P = 0.035).

          Conclusion: ECMO for refractory cardiac arrest shows promising survival rates if protocolised care is applied in conjunction with predefined selection criteria.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: not found
          • Article: not found

          Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

            Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Therapeutic hypothermia is recommended by international guidelines, but the supporting evidence is limited, and the target temperature associated with the best outcome is unknown. Our objective was to compare two target temperatures, both intended to prevent fever. In an international trial, we randomly assigned 950 unconscious adults after out-of-hospital cardiac arrest of presumed cardiac cause to targeted temperature management at either 33°C or 36°C. The primary outcome was all-cause mortality through the end of the trial. Secondary outcomes included a composite of poor neurologic function or death at 180 days, as evaluated with the Cerebral Performance Category (CPC) scale and the modified Rankin scale. In total, 939 patients were included in the primary analysis. At the end of the trial, 50% of the patients in the 33°C group (235 of 473 patients) had died, as compared with 48% of the patients in the 36°C group (225 of 466 patients) (hazard ratio with a temperature of 33°C, 1.06; 95% confidence interval [CI], 0.89 to 1.28; P=0.51). At the 180-day follow-up, 54% of the patients in the 33°C group had died or had poor neurologic function according to the CPC, as compared with 52% of patients in the 36°C group (risk ratio, 1.02; 95% CI, 0.88 to 1.16; P=0.78). In the analysis using the modified Rankin scale, the comparable rate was 52% in both groups (risk ratio, 1.01; 95% CI, 0.89 to 1.14; P=0.87). The results of analyses adjusted for known prognostic factors were similar. In unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause, hypothermia at a targeted temperature of 33°C did not confer a benefit as compared with a targeted temperature of 36°C. (Funded by the Swedish Heart-Lung Foundation and others; TTM ClinicalTrials.gov number, NCT01020916.).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR)

              Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) support under extracorporeal cardiopulmonary resuscitation (eCPR) is the last option and may be offered to selected patients. Several factors predict outcome in these patients, including initial heart rhythm, comorbidities, and bystander cardiopulmonary resuscitation (CPR). We evaluated outcomes of all VA-ECMO patients treated within the last 5 years at our center in respect to low-flow duration during CPR. Methods We report retrospective registry data on all patients with eCPR treated at a university hospital between October 2010 and May 2016. Results A total of 133 patients (mean age 58.7 ± 2.6 years, Simplified Acute Physiology Score II score at admission 48.1 ± 3.4) were included in the analysis. The indication for eCPR was either in-hospital or out-of-hospital cardiac arrest without return of spontaneous circulation (n = 74 and 59, respectively). There was a significant difference in survival rates between groups (eCPR in-hospital cardiac arrest [IHCA] 18.9%, eCPR out-of-hospital cardiac arrest [OHCA] 8.5%; p < 0.042). Mean low-flow duration (i.e., duration of mechanical CPR until VA-ECMO support) was 59.6 ± 5.0 minutes in all patients and significantly shorter in IHCA patients than in OHCA patients (49.6 ± 5.9 vs. 72.2 ± 7.4 minutes, p = 0.001). Low-flow time strongly correlated with survival (p < 0.001) and was an independent predictor of mortality. Conclusions Time to full support is an important and alterable predictor of patient survival in eCPR, suggesting that VA-ECMO therapy should be established as fast as possible in the selected patients destined for eCPR. Electronic supplementary material The online version of this article (doi:10.1186/s13054-017-1744-8) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                Journal
                Crit Care Resusc
                Crit Care Resusc
                Critical Care and Resuscitation
                Elsevier
                1441-2772
                2652-9335
                18 October 2023
                March 2020
                18 October 2023
                : 22
                : 1
                : 26-34
                Affiliations
                [1 ]Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
                [2 ]Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                [3 ]Department of Intensive Care, St Vincent’s Hospital, Sydney, NSW, Australia.
                [4 ]Centre of Applied Medical Research, St Vincent’s Hospital Sydney, NSW, Australia.
                [5 ]University of New South Wales, Sydney, NSW, Australia.
                [6 ]Intensive Care Service, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                [7 ]Greater Sydney Area Helicopter Emergency Medical Service, New South Wales Ambulance Service, Sydney, NSW, Australia.
                [8 ]Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                [9 ]Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                [10 ]Department of Emergency Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                [11 ]Department of Cardiothoracic Surgery St Vincent’s Hospital, Sydney, NSW, Australia.
                [12 ]New South Wales Ambulance Service, Sydney, NSW, Australia.
                [13 ]Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
                Author notes
                [* ]The full list of collaborating authors of the Sydney ECMO Research Interest Group is provided in the online Appendix.
                Article
                S1441-2772(23)00505-7
                10.51893/2020.1.oa3
                10692455
                32102640
                5f5765b7-9c93-466e-a24b-c0af1f003e53
                © 2020 College of Intensive Care Medicine of Australia and New Zealand.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Original Articles

                Comments

                Comment on this article